Gene · 2548
Papers2,709
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 2,709
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Orphan Drugs in Neurology-A Narrative Review. | J Pers Med | 2023 | 36983602 | PubTator, text mining | PubMed |
| Unusual Evolution of Hypertrophic Cardiomyopathy in Non-Compaction Myocardium in a Pompe Disease Patient. | J Clin Med | 2023 | 36983365 | PubTator, text mining | PubMed |
| Identification of Antioxidative Peptides Derived from Arthrospira maxima in the Biorefinery Process after Extraction of C-Phycocyanin and Lipids. | Mar Drugs | 2023 | 36976194 | PubTator, text mining | PubMed |
| Harmonization of Newborn Screening Results for Pompe Disease and Mucopolysaccharidosis Type I. | Int J Neonatal Screen | 2023 | 36975849 | PubTator, text mining | PubMed |
| Blepharoptosis in infantile onset Pompe disease: Histological findings and surgical outcomes. | Mol Genet Metab Rep | 2023 | 36967722 | PubTator, text mining | PubMed |
| Broad Host Tropism of Flaviviruses during the Entry Stage. | Microbiol Spectr | 2023 | 36943072 | PubTator, text mining | PubMed |
Ursonic acid from Artemisia montana exerts anti-diabetic effects through anti-glycating properties, and by inhibiting PTP1B and activating the PI3K/Akt signaling pathway in insulin-resistant C2C12 cells. | Chem Biol Interact | 2023 | 36933777 | PubTator, text mining | PubMed |
| A universal GlycoDesign for lysosomal replacement enzymes to improve circulation time and biodistribution. | Front Bioeng Biotechnol | 2023 | 36911201 | PubTator, text mining | PubMed |
| Ganoderic Acid A and Its Amide Derivatives as Potential Anti-Cancer Agents by Regulating the p53-MDM2 Pathway: Synthesis and Biological Evaluation. | Molecules | 2023 | 36903622 | PubTator, text mining | PubMed |
| Pathophysiology and Management of Fatigue in Neuromuscular Diseases. | Int J Mol Sci | 2023 | 36902435 | PubTator, text mining | PubMed |
| Biochemical Characteristics of iPSC-Derived Dopaminergic Neurons from N370S GBA Variant Carriers with and without Parkinson's Disease. | Int J Mol Sci | 2023 | 36901867 | PubTator, text mining | PubMed |
| Recent advances in CRISPR-based genome editing technology and its applications in cardiovascular research. | Mil Med Res | 2023 | 36895064 | PubTator, text mining | PubMed |
| Identifying potential ligand molecules EGFR mediated TNBC targeting the kinase domain-identification of customized drugs through in silico methods. | Res Pharm Sci | 2023 | 36873279 | PubTator, text mining | PubMed |
| Azithromycin, a potent autophagy inhibitor for cancer therapy, perturbs cytoskeletal protein dynamics. | Br J Cancer | 2023 | 36871041 | PubTator, text mining | PubMed |
Proprioceptors-enriched neuronal cultures from induced pluripotent stem cells from Friedreich ataxia patients show altered transcriptomic and proteomic profiles, abnormal neurite extension, and impaired electrophysiological properties. | Brain Commun | 2023 | 36865673 | PubTator, text mining | PubMed |
| Creatine Deficiency Disorders: Phenotypes, Genotypes, Diagnosis, and Treatment Outcomes. | Turk Arch Pediatr | 2023 | 36856349 | PubTator, text mining | PubMed |
| A multicenter prospective study of next-generation sequencing-based newborn screening for monogenic genetic diseases in China. | World J Pediatr | 2023 | 36847978 | PubTator, text mining | PubMed |
| Enzyme Replacement Therapy (ERT) on Heart Function Changes the Outcome in Patients with Infantile-Onset Pompe Disease: A Familial History. | Case Rep Pediatr | 2023 | 36845322 | PubTator, text mining | PubMed |
| Mono-ADP-ribosylation by PARP10 inhibits Chikungunya virus nsP2 proteolytic activity and viral replication. | Cell Mol Life Sci | 2023 | 36840772 | PubTator, text mining | PubMed |
| The Experience of a Tertiary Reference Hospital in the Study of Rare Neurological Diseases. | Medicina (Kaunas) | 2023 | 36837468 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2548/papers?page=19